CCL2 and metabolic dysfunction-associated steatotic liver disease: A growing number of studies demonstrated that chemokines and their receptors levels were elevated in NAFLD subjects and acted indispensable roles in mediating IR, inflammation, hepatic steatosis and fibrosis, especially chemokine ligand 2 (CCL2), CCL5, and CCL20 (60, 69).